Drawing for ANDNA

USPTO serial 75938115

ANDNA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANDNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael R. Graham

MICHAEL R GRAHAM MARSHALL O'TOOLE GERSTEIN MURRAY & BORUNSTE 6300 SEARS TWR233 S WACKER DRCHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, biochemicals and reagents, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, markers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase chain reaction, PCR, process and the rolling circle amplification, RCA, process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis; reagents for recombinant protein expression purification, chromatography media; electrophoresis; spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagents saline solution and reagent-coated paper all for scientific and laboratory use; fissionable chemical elements; radioactive elements and isotopes for industrial, scientific, and research purposes; radioactive sources and standards for use in radiographic techniques; radioactive sources for use in non-destructive testing, purification or sterilizing techniques for use in industry, science and research; chemical preparations, kits and reagents for analysis or diagnosis used for scientific purposes, namely, cell separation and culture; nucleic acid purification; and radionuclidesACTIVE—
005Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical, scientific, and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in spin signal diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solutionACTIVE—
009Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films including automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus manufacturing oligonucleotides; apparatus for microarrays; microarray slides; glassware; vials and microvials; microtitre plates; and parts and fittings for the aforesaid goodsACTIVE—
010Surgical and medical apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radio therapy, comprised of medical needles, suture needles, implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT, scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; vials access cannulas; syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes and parts and fittings for the aforesaid goodsACTIVE—
042Advisory services for pharmaceutical companies in the field of purification and chromatography research and development services in the field of pharmaceutical and life sciences; high through put screening assays for drug development services; customer synthesis services consisting of isotopically labelling chemical biological molecules; and analytical services in the chemical analytical field, the diagnostic field, and the medical imaging fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 12, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 19, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 25, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 5, 2001NPUBNOTICE OF PUBLICATION—
Aug 15, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2001CNEAEXAMINERS AMENDMENT MAILED—
Jul 10, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 12, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2000DOCKASSIGNED TO EXAMINER—
Aug 10, 2000DOCKASSIGNED TO EXAMINER—
Aug 10, 2000DOCKASSIGNED TO EXAMINER—
Jun 30, 2000UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—

Frequently asked questions

Related guidance